I. McDonald

发表

Reductions in beta-amyloid concentrations in vivo by the gamma-secretase inhibitors BMS-289948 and BMS-299897.

S. Wagner, B. Lamb, D. Barten, 2005, Biochemical pharmacology.

3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity.

Mark Washburn, N. Cosford, L. Bristow, 2003, Journal of medicinal chemistry.

Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site.

F. Salituro, B. Harrison, C. J. Schmidt, 1990, Molecular pharmacology.

Inhibition of Monoamine Oxidase Selectively in Brain Monoamine Nerves Using the Bioprecursor (E‐β‐Fluoromethylene‐m‐Tyrosine (MDL 72394), a Substrate for Aromatic L‐Amino Acid Decarboxylase

P. J. Lewis, J. Fozard, A. Sleight, 1985, Journal of neurochemistry.

(E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine: a selective, enzyme-activated inhibitor of type B monoamine oxidase.

J. Fozard, M. Palfreyman, I. McDonald, 1984, Journal of medicinal chemistry.

Inhibition of rat aorta semicarbazide-sensitive amine oxidase by 2-phenyl-3-haloallylamines and related compounds.

M. Palfreyman, I. McDonald, P. Bey, 1987, Biochemical pharmacology.

MDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease

J. Fozard, M. Palfreyman, I. McDonald, 1989, Journal of neural transmission. Parkinson's disease and dementia section.

MDL 72145, an Enzyme‐Activated Irreversible Inhibitor with Selectivity for Monoamine Oxidase Type B

M. Palfreyman, I. McDonald, P. Bey, 1984, Journal of neurochemistry.

PXS-4681A, a Potent and Selective Mechanism-Based Inhibitor of SSAO/VAP-1 with Anti-Inflammatory Effects In Vivo

H. Schilter, J. Foot, W. Jarolimek, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Complexes of binucleating ligands. XVIII. Complexes incorporating two independent species at a (Pd(II))2 site normally occupied by a bridge. The crystal structure of a complex with chloride and glycine ester bound at the (Pd(II))2 site

R. Robson, I. McDonald, B. F. Hoskins, 1986 .

SOME CLINICAL APPLICATIONS OF A RAPID PREGNANCY TEST WITH THE USE OF THE MALE TOAD (BUFO MARINUS)

I. McDonald, H. P. Taft, 1953, The Medical journal of Australia.

Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis.

I. McDonald, J. F. French, B. M. Baron, 1992, European journal of pharmacology.

Conformationally restricted analogues of nicotine and anabasine.

T. Rao, F. Menzaghi, N. Cosford, 1998, Bioorganic & medicinal chemistry letters.

(R)-4-oxo-5-phosphononorvaline: a new competitive glutamate antagonist at the NMDA receptor complex.

H. White, I. McDonald, B. M. Baron, 1990, Journal of medicinal chemistry.

3-Amino-5-hydroxybenzoic acid as a key intermediate in ansamycin and maytansinoid biosynthesis

I. McDonald, R. Rickards, J. J. Kibby, 1980 .

(E)-.beta.-(Fluoromethylene)-m-tyrosine: a substrate for aromatic L-amino acid decarboxylase liberating an enzyme-activated irreversible inhibitor of monoamine oxidase

M. Palfreyman, I. McDonald, J. Wagner, 1984 .

Hierarchy of quantized Hall states in double-layer electron systems

M. Greiter, I. McDonald, 1993 .

Synthesis of dihydropyridone scaffolds on solid support: Resin activation/capture approach/REACAP technology

B. Muñoz, I. McDonald, Chixu Chen, 1998 .

Resin activation capture technology: libraries from stabilized acyl-pyridinium on solid support.

B. Muñoz, I. McDonald, C. Chen, 2000, Biotechnology and bioengineering.

Structures of nine quinones isolated from two species

I. McDonald, R. Retallack, K. Joshi, 1975 .

Competitive NMDA receptor antagonists; (R)-4-Oxo-5-phosphononorvaline structure-activity relationships

I. McDonald, B. M. Baron, J. Whitten, 1993 .

Synthesis of 3()-phosphonoacetyl-2()-piperidinecarboxylic acid, a conformationally-restricted glutamate antagonist

I. McDonald, R. Cube, B. M. Baron, 1991 .

Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships.

M. Palfreyman, I. McDonald, P. Bey, 1985, Journal of medicinal chemistry.

The Crystal and Molecular Structure of the Trinuclear Complex Bis[(μ-S)-α,α′-{(2-mercapto-5-methylbenzene-1,3-diyl)di(methylidyne)di(azino)}bis(cyclohexane-methanol)ato(3-)]tripalladium(II), L2Pd3. A New Coordination Mode for the Robson-Type Ligand L3-

I. McDonald, B. E. Hoskins, 1989 .

ELECTROEJACULATION OF THE PARAPLEGIC MALE FOLLOWED BY PREGNANCY

I. McDonald, R. Thomas, G. McLeish, 1975, The Medical journal of Australia.

Overview: Inhibitors of Enzymes Involved in Catecholamine Biosynthesis and Degradation

I. McDonald, M. W. Dudley, 1992 .

(S)-(-)-5-ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine maleate (SIB-1508Y): a novel anti-parkinsonian agent with selectivity for neuronal nicotinic acetylcholine receptors.

P. Adams, K. Stauderman, T. Rao, 1996, Journal of medicinal chemistry.

3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.

J. Kehne, F. Salituro, B. Harrison, 1992, Journal of medicinal chemistry.

Synthesis of (E)-β-fluoromethyleneglutamic acid

M. Palfreyman, I. McDonald, M. Jung, 1985 .

A. New Synthesis of Triasteranedione

I. McDonald, H. Musso, A. Dreiding, 1973 .

Multisubstrate inhibition of 4-hydroxybenzoate 3-monooxygenase.

F. Salituro, I. McDonald, B. Lippert, 1994, Journal of medicinal chemistry.

Chapter 15 Semicarbazide Sensitive Amine Oxidase and Vascular Adhesion Protein-1: One Protein Being Validated as a Therapeutic Target for Inflammatory Diseases

E. Dam, P. Yin, J. Foot, 2007 .

Competitive NMDA receptor antagonists: synthesis of β-ketophosphonate-substituted piperidine carboxylic acid derivatives

I. McDonald, R. Cube, B. M. Baron, 1993 .

Chapter 7 - Recent Progress In Antiepileptic Drug Research

N. Cosford, I. McDonald, E. Schweiger, 1998 .

Chapter 5. Nicotinic Acetylcholine Receptors: Molecular Biology, Chemistry and Pharmacology

N. Cosford, J. Vernier, I. McDonald, 1995 .

Synthesis and crystal structure of 7,7a,8,9,11,11a-Hexahydro-7,7,10-trimethyl-1,10-epoxy-10H-benz[de]anthracen-6-ol

J. Cannon, A. Willis, A. White, 1975 .

Triasteranetrione from Triasteranedione

C. Chapleo, I. McDonald, A. Dreiding, 1975 .

Extraction procedures for some common drugs in clinical and forensic toxicology.

I. McDonald, L. Hackett, L. Dusci, 1976, Journal of forensic sciences.

Recombinant human receptors and functional assays in the discovery of altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist.

T. Rao, N. Cosford, R. Siegel, 2000, Pharmaceutica acta Helvetiae.

Facile synthesis of L-kynurenine

F. Salituro, I. McDonald, 1988 .

Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist.

P. Adams, K. Stauderman, T. Rao, 1997, The Journal of pharmacology and experimental therapeutics.

Dual enzyme-activated irreversible inhibition of monoamine oxidase

M. Palfreyman, I. McDonald, J. Wagner, 1986 .

Synthesis and biological activity of sulfoximine-modified myristic acid analogues

I. McDonald, G. Ku, T. Bowlin, 1993 .

Suture of the cervix for inevitable miscarriage.

I. McDonald, 1957, The Journal of obstetrics and gynaecology of the British Empire.

Nitric oxide synthesis in the CNS endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues.

H. Cheng, I. McDonald, B. M. Baron, 1991, Life sciences.

Syntheses of -2-fluoromethy--tyrosine and -2-difluoromethyl--tyrosine as potential inhibitors of tyrosine hydroxylase

I. McDonald, J. Sabol, M. Jung, 1991 .

Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domain

F. Salituro, A. Bitonti, J. Dumont, 1996, The Journal of Steroid Biochemistry and Molecular Biology.

Design and early clinical evaluation of selective inhibitors of monoamine oxidase

A. Sjoerdsma, P. Schechter, M. Palfreyman, 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Reductions in β-amyloid concentrations in vivo by the γ-secretase inhibitors BMS-289948 and BMS-299897

S. Wagner, B. Lamb, D. Barten, 2005 .

A general preparation of fluoroallylamine enzyme inhibitors incorporating a β-substituted heteroatom

I. McDonald, P. Bey, 1985 .

Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.

F. Salituro, B. Harrison, J. Turner, 1992, The Journal of pharmacology and experimental therapeutics.

Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B.

Andrea Mattevi, A. Mattevi, D. Edmondson, 2008, Journal of medicinal chemistry.

4-[(Carboxymethyl)oxy]- and 4-[(carboxymethyl)amino]-5,7-dichloroquinoline-2-carboxylic acid: new antagonists of the strychnine-insensitive glycine binding site on the N-methyl-D-aspartate receptor complex.

B. Harrison, I. McDonald, B. M. Baron, 1990, Journal of medicinal chemistry.

Overview: Inhibition of Nitric Oxide Biosynthesis

I. McDonald, J. Whitten, 1992 .

Syntheses of 5-n-Alkylresorcinol dimethyl ethers and 1,14-Bis(3,5-dimethoxyphenyl) tetradecane via β-keto sulphone intermediates

I. McDonald, G. Vinciguerra, J. Cannon, 1973 .

The ansamycin antibiotic actamycin. I. Definition of structural features by deuterium labelling

M. Allen, I. McDonald, R. Rickards, 1981 .

A new crystal form of human vascular adhesion protein 1.

J. Newman, T. Peat, J. Guss, 2010, Acta crystallographica. Section F, Structural biology and crystallization communications.

Gas-liquid chromatographic determination of theophylline in human plasma.

I. McDonald, L. Hackett, L. Dusci, 1975, Journal of chromatography.

Gas-Liquid chromatographic determination of theophy-line in human plasma

I. McDonald, L. Hackett, L. Dusci, 1975 .

4-[[2-(1-Methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A): a novel cognitive enhancer with selectivity for neuronal nicotinic acetylcholine receptors.

B. Bontempi, T. Rao, F. Menzaghi, 1999, Journal of medicinal chemistry.

Enzyme-activated antagonists of the strychnine-insensitive glycine/NMDA receptor.

R. Schwarcz, F. Salituro, P. Guidetti, 1994, Journal of medicinal chemistry.

Haloallylamine inhibitors of MAO and SSAO and their therapeutic potential.

M. Palfreyman, I. McDonald, G. Cremer, 1994, Journal of neural transmission. Supplementum.

The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1).

P. Yin, J. Foot, A. Holt, 2012, Bioorganic & medicinal chemistry letters.

Structural and mechanistic studies of mofegiline inhibition of recombinant human monoamine oxidase B.

A. Mattevi, D. Edmondson, I. McDonald, 2008, Journal of medicinal chemistry.

3-(2-carboxyindol-3-yl)propionic acid derivatives: antagonists of the strychnine-insensitive glycine receptor associated with the N-methyl-D-aspartate receptor complex.

F. Salituro, B. Harrison, I. McDonald, 1990, Journal of medicinal chemistry.

A Practical and Efficient Synthesis of the Selective Neuronal Acetylcholine-Gated Ion Channel Agonist (S)-(−)-5-Ethynyl-3-(1-methyl-2-pyrrolidinyl)pyridine Maleate (SIB-1508Y)

N. Cosford, I. McDonald, L. Bleicher, 1998 .